Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:224:12-13.
doi: 10.1016/j.imlet.2020.05.002. Epub 2020 May 28.

Are there any association between COVID-19 severity and immunosuppressive therapy?

Affiliations
Comment

Are there any association between COVID-19 severity and immunosuppressive therapy?

Ahmad Hormati et al. Immunol Lett. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Comment on

  • Effective treatment of severe COVID-19 patients with tocilizumab.
    Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Xu X, et al. Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29. Proc Natl Acad Sci U S A. 2020. PMID: 32350134 Free PMC article.

References

    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55 - PMC - PubMed
    1. Arshad Ali S., Baloch M., Ahmed M., Arshad Ali A., Iqbal M. The outbreak of coronavirus disease 2019 (COVID-19)—An emerging global threat. J Infect Public Health. 2020 doi: 10.1016/j.jiph.2020.02.033. - DOI - PMC - PubMed
    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401–402. - PMC - PubMed
    1. X. Xu, M. Han, T. Li, X.W. Li, W. Sun, D. Wang, et al. Effective treatment of severe COVID-19 patients with Tocilizumab. ChinaXiv. 202003.00026v1. - PMC - PubMed
    1. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 doi: 10.1016/S0140-6736(20)30628-0. - DOI - PMC - PubMed

Substances